Literature DB >> 24351374

The effects of different IV fat emulsions on clinical outcomes in critically ill patients.

Christina E Edmunds1, Rebecca A Brody, J Scott Parrott, Susan M Stankorb, Daren K Heyland.   

Abstract

OBJECTIVE: To examine the effects of different IV fat emulsions on clinical outcomes in critically ill patients.
DESIGN: Secondary analysis of data from a prospective multicenter study.
SETTING: An international sample of ICUs. PATIENTS: Adult patients who were admitted to the ICU for more than 72 hours, were mechanically ventilated within 48 hours, received exclusive parenteral nutrition for more than or equal to 5 days, and did not change IV fat emulsion type during the data collection period.
INTERVENTIONS: Demographic and clinical data were collected for up to 12 days, until death, or discharge from the ICU, whichever came first. Clinical outcomes were recorded at 60 days following ICU admission. MEASUREMENTS: Lipid-free, soybean, medium-chain triglyceride, olive, and fish oils in parenteral nutrition were compared using an adjusted Cox proportional hazard model to examine time to termination of mechanical ventilation alive, time to ICU discharge alive, and time to hospital discharge alive. MAIN
RESULTS: A total of 451 patients were included in this study: 70 (15.5%) in the lipid-free group, 223 (49.5%) in the soybean oil group, 65 (14.4%) in the medium-chain triglyceride group, 74 (16.4%) in the olive oil group, and 19 (4.9%) in the fish oil group. When compared with lipid-free parenteral nutrition, patients who received fish oil had a faster time to ICU discharge alive (hazard ratio, 1.84; 95% CI, 1.01-3.34; p = 0.05). When compared with soybean oil, patients who received olive oil or fish oil had a shorter time to termination of mechanical ventilation alive (hazard ratio, 1.43; 95% CI, 1.06-1.93; p = 0.02 and hazard ratio, 1.67; 95% CI, 1.00-2.81; p = 0.05, respectively) and a shorter time to ICU discharge alive (hazard ratio, 1.76; 95% CI, 1.30-2.39; p < 0.001 and hazard ratio, 2.40; 95% CI, 1.43-4.03; p = 0.001, respectively).
CONCLUSIONS: Use of alternative IV fat emulsions in parenteral nutrition, particularly olive and fish oil, was associated with improved clinical outcomes.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24351374     DOI: 10.1097/CCM.0000000000000146

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  11 in total

1.  Significant Published Articles for Pharmacy Nutrition Support Practice in 2014 and 2015.

Authors:  Roland N Dickerson; Vanessa J Kumpf; Allison B Blackmer; Angela L Bingham; Anne M Tucker; Joseph V Ybarra; Michael D Kraft; Todd W Canada
Journal:  Hosp Pharm       Date:  2016-07

Review 2.  Intravenous Fat Emulsion Formulations for the Adult and Pediatric Patient: Understanding the Differences.

Authors:  Lorenzo Anez-Bustillos; Duy T Dao; Meredith A Baker; Gillian L Fell; Mark Puder; Kathleen M Gura
Journal:  Nutr Clin Pract       Date:  2016-08-16       Impact factor: 3.080

3.  Updates in Nutrition Support for Critically Ill Adult Patients.

Authors:  Diana Wells Mulherin; Sarah V Cogle
Journal:  Hosp Pharm       Date:  2017-01

Review 4.  Intravenous fish oil lipid emulsions in critically ill patients: an updated systematic review and meta-analysis.

Authors:  William Manzanares; Pascal L Langlois; Rupinder Dhaliwal; Margot Lemieux; Daren K Heyland
Journal:  Crit Care       Date:  2015-04-16       Impact factor: 9.097

Review 5.  Management of parenteral nutrition in critically ill patients.

Authors:  Paolo Cotogni
Journal:  World J Crit Care Med       Date:  2017-02-04

6.  Fish Oil Enriched Intravenous Lipid Emulsions Reduce Triglyceride Levels in Non-Critically Ill Patients with TPN and Type 2 Diabetes. A Post-Hoc Analysis of the INSUPAR Study.

Authors:  Jose Abuín-Fernández; María José Tapia-Guerrero; Rafael López-Urdiales; Sandra Herranz-Antolín; Jose Manuel García-Almeida; Katherine García-Malpartida; Mercedes Ferrer-Gómez; Emilia Cancer-Minchot; Luis Miguel Luengo-Pérez; Julia Álvarez-Hernández; Carmen Aragón Valera; Julia Ocón-Bretón; Álvaro García-Manzanares; Irene Bretón-Lesmes; Pilar Serrano-Aguayo; Natalia Pérez-Ferre; Juan José López-Gómez; Josefina Olivares-Alcolea; Carmen Arraiza-Irigoyen; Cristina Tejera-Pérez; Jorge Daniel Martínez-González; Ana Urioste-Fondo; Ángel Luis Abad-González; María José Molina-Puerta; Ana Zugasti-Murillo; Juan Parra-Barona; Irela López-Cobo; And Gabriel Olveira-Fuster
Journal:  Nutrients       Date:  2020-05-27       Impact factor: 5.717

Review 7.  Biological and Clinical Aspects of an Olive Oil-Based Lipid Emulsion-A Review.

Authors:  Wei Cai; Phillip C Calder; Maria F Cury-Boaventura; Elisabeth De Waele; Julie Jakubowski; Gary Zaloga
Journal:  Nutrients       Date:  2018-06-15       Impact factor: 5.717

Review 8.  Intravenous Lipid Emulsions to Deliver Bioactive Omega-3 Fatty Acids for Improved Patient Outcomes.

Authors:  Philip C Calder
Journal:  Mar Drugs       Date:  2019-05-08       Impact factor: 5.118

9.  A quality improvement program with nutrition therapy: restriction of lipid emulsions in cardiac surgical patients.

Authors:  Jian Gao; Guo-Wei Tu; Chun-Sheng Wang; Du-Ming Zhu; Lan Liu; Hua Liu; Xiao-Mei Yang; Zhe Luo
Journal:  J Thorac Dis       Date:  2018-02       Impact factor: 2.895

10.  Resolution of inflammation and sepsis survival are improved by dietary Ω-3 fatty acids.

Authors:  Andreas Körner; Martin Schlegel; Julia Theurer; Hannes Frohnmeyer; Michael Adolph; Marieke Heijink; Martin Giera; Peter Rosenberger; Valbona Mirakaj
Journal:  Cell Death Differ       Date:  2017-10-20       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.